Abstract Body

Background:

The estimated number of new HIV infections in the United States dropped 12% in 2021 compared to 2017, but the racial and ethnic disparities in HIV infection persist. Community-level factors contributing to social vulnerabilities (e.g., poverty, lack of access to health care and services) may affect HIV outcomes. This analysis assessed the association between county-level social vulnerability and CDC-funded HIV testing and HIV positivity rates, and whether the association varies by demographic characteristics, testing site type, and Phase I Ending the HIV Epidemic (EHE) jurisdiction status in 2020-2022.

Methods:

We used testing data submitted to CDC by 60 state and local health departments (HDs) and 117 community-based organizations (CBOs). We combined HIV testing data with the latest county-level composite measure of economic, medical, and social vulnerability captured by the Minority Health Social Vulnerability Index (MHSVI). HIV testing and HIV positivity rates were analyzed by age, gender, race/ethnicity, testing site type, and Phase I EHE jurisdiction status and stratified by low, moderate, and high MHSVI scores. We calculated prevalence ratio (PR) with a 95% confidence interval (CI) to measure relative disparity by comparing county tracts with high vs. low MHSVI scores.

Results:

In 2020-2022, CDC-funded HDs and CBOs conducted 4,906,507 HIV tests: 113,721 (2.3%) in low, 583,307 (11.9%) in moderate, and 4,209,479 (85.8%) in high social vulnerability counties. Overall HIV positivity rate was 1.03%, including 0.52% in low, 0.63% in moderate, and 1.09% in high social vulnerability counties. HIV positivity rate was higher in high than in low social vulnerability counties (PR=2.12; 95% CI=1.95-2.30). In addition, the relative disparity in HIV testing and positivity rates was consistently higher in high MHSVI counties than in low MHSVI counties regardless of age groups, gender, race/ethnicity, testing site type, and the Phase I EHE jurisdiction status.

Conclusions:

HIV testing supported by CDC funding, and HIV positivity rates are higher in communities characterized by high levels of social vulnerability. These findings suggest that CDC’s HIV testing efforts are directed to the most vulnerable communities and are identifying persons with HIV infection. Continued monitoring of the association between county-level social vulnerability and HIV positivity rates would be informative in guiding HIV testing efforts and resource allocation for achieving EHE goals.